CXI Healthcare Technology Group Limited (KOSDAQ: 900120)
South Korea
· Delayed Price · Currency is KRW
82.00
-2.00 (-2.38%)
Sep 10, 2024, 9:00 AM KST
CXI Healthcare Technology Group Ratios and Metrics
Market cap in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 9, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 |
Market Capitalization | 23,635 | 26,536 | 31,491 | 37,709 | 25,724 | 46,811 | |
Market Cap Growth | 24.91% | -15.73% | -16.49% | 46.59% | -45.05% | -14.34% | |
Enterprise Value | -125,242 | -63,434 | -24,406 | 22,404 | -269,806 | -280,524 | |
Last Close Price | 82.00 | 160.00 | 256.00 | 323.00 | 233.00 | 424.00 | |
PE Ratio | 0.84 | 3.45 | 5.33 | 7.05 | -0.26 | -0.65 | |
PS Ratio | 0.26 | 0.37 | 0.31 | 0.36 | 0.41 | 0.36 | |
PB Ratio | 0.05 | 0.06 | 0.08 | 0.10 | 0.07 | 0.10 | |
P/FCF Ratio | 0.78 | 0.84 | 0.88 | -0.19 | -0.23 | -0.81 | |
P/OCF Ratio | 0.78 | 0.84 | 0.88 | 4.32 | -0.58 | -0.81 | |
EV/Sales Ratio | -1.37 | -0.89 | -0.24 | 0.21 | -4.26 | -2.17 | |
EV/EBITDA Ratio | -2.23 | -2.04 | -0.76 | 0.97 | 5.62 | 3.92 | |
EV/EBIT Ratio | -5.53 | -8.89 | -3.88 | 4.95 | 4.36 | 3.85 | |
EV/FCF Ratio | -2.15 | -2.01 | -0.68 | -0.11 | 2.45 | 4.83 | |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | |
Debt / EBITDA Ratio | 0.00 | 0.03 | 0.01 | 0.04 | - | - | |
Debt / FCF Ratio | 0.00 | 0.03 | 0.01 | 0.00 | -0.02 | -0.03 | |
Asset Turnover | 0.15 | 0.17 | 0.25 | 0.28 | 0.15 | 0.25 | |
Inventory Turnover | 209.52 | 163.38 | 84.46 | 48.16 | 39.71 | 39.18 | |
Quick Ratio | 61.71 | 42.89 | 11.24 | 4.81 | 26.66 | 15.38 | |
Current Ratio | 62.18 | 43.39 | 11.44 | 5.01 | 27.33 | 16.10 | |
Return on Equity (ROE) | 4.85% | 1.81% | 1.51% | 1.40% | -24.63% | -14.55% | |
Return on Assets (ROA) | 2.38% | 1.06% | 0.97% | 0.76% | -9.31% | -8.84% | |
Return on Capital (ROIC) | 2.40% | 1.07% | 0.99% | 0.78% | -9.62% | -9.36% | |
Earnings Yield | 118.71% | 28.37% | 18.99% | 13.52% | -382.66% | -150.86% | |
FCF Yield | 128.55% | 119.07% | 114.25% | -520.21% | -427.70% | -124.12% | |
Buyback Yield / Dilution | -38.69% | -32.38% | -10.22% | -0.77% | - | - | |
Total Shareholder Return | -38.69% | -32.38% | -10.22% | -0.77% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.